326 related articles for article (PubMed ID: 30352568)
1. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
[TBL] [Abstract][Full Text] [Related]
2. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
[TBL] [Abstract][Full Text] [Related]
3. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N
BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137
[TBL] [Abstract][Full Text] [Related]
4. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
Alibhai SMH; Papadopoulos E; Mina DS; Ritvo P; Tomlinson G; Sabiston CM; Durbano S; Bremner KE; Chiarotto J; Matthew A; Warde P; O'Neill M; Culos-Reed SN
J Geriatr Oncol; 2024 Jan; 15(1):101646. PubMed ID: 37976654
[TBL] [Abstract][Full Text] [Related]
5. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Kilgour A; Lau YK
BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
[TBL] [Abstract][Full Text] [Related]
10. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
[TBL] [Abstract][Full Text] [Related]
11. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
Trials; 2014 Sep; 15():354. PubMed ID: 25199619
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
13. Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial.
Mundell NL; Owen PJ; Dalla Via J; Macpherson H; Daly RM; Livingston PM; Rantalainen T; Foulkes S; Millar J; Murphy DG; Fraser SF
BMJ Open; 2022 Jun; 12(6):e060189. PubMed ID: 35750461
[TBL] [Abstract][Full Text] [Related]
14. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy.
Edmunds K; Reeves P; Scuffham P; Galvão DA; Newton RU; Jones M; Spry N; Taaffe DR; Joseph D; Chambers SK; Tuffaha H
Appl Health Econ Health Policy; 2020 Oct; 18(5):727-737. PubMed ID: 32107736
[TBL] [Abstract][Full Text] [Related]
16. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
[TBL] [Abstract][Full Text] [Related]
17. Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study.
Reimer N; Hafke R; Wrensch M; Horst P; Bloch W; Hahn T; Kirchhoff A; Kluck KL; Stein J; Baumann FT
Contemp Clin Trials; 2022 Mar; 114():106685. PubMed ID: 35065281
[TBL] [Abstract][Full Text] [Related]
18. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
[TBL] [Abstract][Full Text] [Related]
19. Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.
Alibhai SMH; Papadopoulos E; Durbano S; Tomlinson G; Mina DS; Ritvo P; Sabiston CM; Matthew AG; Chiarotto J; Sidani S; Culos-Reed SN
Front Oncol; 2022; 12():1033229. PubMed ID: 36578945
[TBL] [Abstract][Full Text] [Related]
20. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]